Home
/
Ocugen, Inc.
/
Financials
/
Quarterly
Ocugen, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Ocugen, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$0
Nov 9, 2021
Q2
2021
Jun 30, 2021
$0
Aug 6, 2021
Q3
2021
Sep 30, 2020
$0
Nov 9, 2021
Q2
2021
Jun 30, 2020
$43.0K
Aug 6, 2021
Q3
2020
Sep 30, 2019
$0
Nov 6, 2020
Q2
2020
Jun 30, 2019
$0
Aug 14, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.75M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$1.37M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$1.48M
May 9, 2025
Q3
2025
Sep 30, 2024
$1.14M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$1.14M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$1.01M
May 9, 2025
Q3
2024
Sep 30, 2023
$3.70M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$485.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$443.0K
May 14, 2024
Q1
2019
Mar 31, 2019
$0
May 15, 2019
Q3
2018
Sep 30, 2018
$0
Nov 8, 2018
Q2
2018
Jun 30, 2018
$0
Aug 9, 2018
Q1
2019
Mar 31, 2018
$0
May 15, 2019
Q3
2018
Sep 30, 2017
$0
Nov 8, 2018
Q2
2018
Jun 30, 2017
$0
Aug 9, 2018
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$0
May 10, 2018
Q3
2017
Sep 30, 2017
$0
Nov 9, 2017
Q2
2017
Jun 30, 2017
$0
Aug 10, 2017
Q1
2018
Mar 31, 2017
$0
May 10, 2018
Q3
2017
Sep 30, 2016
$0
Nov 9, 2017
Q2
2017
Jun 30, 2016
$0
Aug 10, 2017
Q1
2017
Mar 31, 2016
$0
May 11, 2017
Q3
2016
Sep 30, 2015
$0
Nov 10, 2016
Q2
2016
Jun 30, 2015
$0
Aug 11, 2016
Q1
2016
Mar 31, 2015
$0
May 12, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($20.05M)
Nov 5, 2025
Q3
2025
Jun 30, 2025
($14.74M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($14.74M)
Aug 4, 2025
Q2
2025
Mar 31, 2025
($15.35M)
Aug 4, 2025
Q3
2025
Mar 31, 2025
($15.35M)
Nov 5, 2025
Q1
2025
Mar 31, 2025
($15.35M)
May 9, 2025
Q3
2025
Sep 30, 2024
($12.97M)
Nov 5, 2025
Q1
2025
Jun 30, 2024
($15.28M)
May 9, 2025
Q3
2025
Jun 30, 2024
($15.28M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($15.28M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
($11.92M)
May 9, 2025
Q2
2025
Mar 31, 2024
($11.92M)
Aug 4, 2025
Q3
2025
Mar 31, 2024
($11.92M)
Nov 5, 2025
Q3
2024
Sep 30, 2023
($11.72M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($23.07M)
Aug 8, 2024
Q3
2024
Jun 30, 2023
($23.07M)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($17.33M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($17.33M)
May 14, 2024
Q3
2024
Mar 31, 2023
($17.33M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($21.92M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.63M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($13.80M)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($14.50M)
May 9, 2025
Q3
2025
Sep 30, 2024
($13.25M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($15.45M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
($12.22M)
May 9, 2025
Q3
2024
Sep 30, 2023
($12.43M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($23.54M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($18.04M)
May 14, 2024
Q3
2023
Sep 30, 2022
($23.12M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($19.57M)
Aug 21, 2023
Q1
2023
Mar 31, 2022
($18.03M)
May 5, 2023
Q3
2022
Sep 30, 2021
($10.79M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($25.61M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($7.06M)
May 6, 2022
Q3
2021
Sep 30, 2020
($10.18M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($3.37M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($3.93M)
May 7, 2021
Q3
2020
Sep 30, 2019
($2.71M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($2.33M)
Aug 14, 2020